Immunodiagnostic Systems Hldgs PLC Directorate Change (1776V)
October 31 2017 - 1:22PM
UK Regulatory
TIDMIDH
RNS Number : 1776V
Immunodiagnostic Systems Hldgs PLC
31 October 2017
The information contained within this announcement is deemed by
the Company to constitute inside information as stipulated under
the Market Abuse Regulation (EU) No. 596/2014. Upon the publication
of this announcement via the Regulatory Information Service, this
inside information is now considered to be in the public domain
31 October 2017
Immunodiagnostic Systems Holdings plc
Directorate Change
Immunodiagnostic Systems Holdings plc ("IDS" or the "Company"),
a specialist producer of manual and automated diagnostic testing
kits and instruments for the clinical market, today announces that
Regis Duval, Chief Executive Officer, has stepped down from his
role as a Director of the Company and all associated directorships
of IDS with immediate effect. Regis is stepping down for personal
reasons in order to spend more time with his family in
Luxemburg.
Since his appointment as CEO in March 2017, Regis has initiated
several initiatives to halt the decrease in revenues IDS has been
experiencing, in particular working on employee engagement across
the Company, improving the operations and filling several important
management positions. The role of Chief Executive Officer has been
taken over by Jaap Stuut with immediate effect. Jaap has been with
the Company since 2013, and was previously responsible for the
global marketing and corporate development of the Company as well
as having the direct sales responsibility for the USA and Brazil.
Before this he was responsible for global marketing.
Prior to joining IDS, Jaap worked at SHO Centra for Medical
Diagnostics, where he held the position of Chief Operating Officer,
responsible for Sales, Marketing & Operations. Additionally he
worked at Roche Diagnostics where he held several senior Sales
& Marketing roles in the Clinical Medical Diagnostics team.
Jaap is a Dutch national and holds an MBA from Bradford University
School of Management.
Dr Burkhard Wittek, Non-Executive Chairman of IDS, commented:
"IDS would like to thank Regis for his contribution to IDS during
the time he spent with us. The improvement in employee engagement
achieved in his time is testimony to his leadership skills. He is
also leaving us a simplified organization with all key positions
filled. We wish him all the best in his family life and future
career.
I would like to welcome Jaap as the new CEO. When I became
Chairman of the Company, Jaap was a key member of the marketing
department. In the years since, he was first promoted to lead the
marketing department, then added the corporate development function
to his remit, and finally taking on certain direct sales
responsibilities.
What IDS now needs more than ever is a strengthening of the
sales and marketing capabilities - and that is exactly what Jaap
brings to the team. He will continue to focus on spending time in
the field with our sales organization, key clients and opinion
leaders. I wish him success and look forward to continue the good
work and open communication with the Board."
The following information is disclosed pursuant to Schedule Two,
paragraph (g) of the AIM Rules for Companies:
Full name and age: Jaap Stuut (aged 47).
Mr. Stuut does not currently hold any ordinary shares in
Immunodiagnostic Systems Holdings plc.
Current Directorships or Partnerships:
Jaap Stuut Beheer BV
No further information in connection with his appointment is
required to be disclosed under Schedule Two, paragraph (g) of the
Aim Rules for Companies.
For further information:
Immunodiagnostic Systems Holdings plc Tel: +44 (0) 191 519 0660
Burkhard Wittek, Non-Executive Chairman
Paul Martin, Group Finance Director
Peel Hunt LLP Tel: +44 (0) 20 7418 8900
James Steel
Oliver Jackson
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAWGGUPUUPMGRG
(END) Dow Jones Newswires
October 31, 2017 14:22 ET (18:22 GMT)
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Apr 2024 to May 2024
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From May 2023 to May 2024